Jennifer Lewis

Jennifer Lewis has a diverse background in quality and regulatory affairs, with roles in both the pharmaceutical and consumer goods industries. Jennifer currently serves as the Sr. Director of Quality Operations - Internal & External Manufacturing at Taysha Gene Therapies. Prior to this, they held roles at Nomax Inc as the Senior Director of Quality & Regulatory Affairs and the Director of Quality & Regulatory Affairs. Jennifer also worked at Henkel as the SHEQ Manager, leading the quality, environmental, health & safety organizations. Jennifer also has experience at Mallinckrodt Pharmaceuticals, where they served as the Sr. Manager - Corporate EHS and the Lead Quality Systems Integration Analyst. Jennifer's earlier experience includes roles at Dr Pepper / 7UP as a Quality Control Technician.

Jennifer Lewis's education history begins in 2001 when they enrolled at Southeast Missouri State University. Jennifer completed their Bachelor of Science (BS) degree in Chemistry in 2003. Following that, they attended Florida Metropolitan University from 2003 to 2006, where they obtained their Master of Science (M.S.) degree in Criminal Science.

In terms of certifications, Jennifer Lewis obtained a Regulatory Affairs Certificate: Dual and a Regulatory Affairs Certificate: Medical Devices from the Regulatory Affairs Certification Program in May 2021. Additionally, they achieved an ISO 9001 Lead Auditor certification in November 2017.

There are other certifications listed, such as Certified Lean Leader, ISO 13485 Lead Auditor, ISO 14001 Internal Auditor, and ISO 45001 Internal Auditor. However, there is no information provided regarding the institutions or specific months and years when these certifications were obtained.